Aldeyra Therapeutics, Inc. (ALDX) Stock Total Returns
Growth of $10,000 chart
2021-06-03 to 2026-06-03 to
$
%
%
Loading chart…
Investment Performance
Final Value
$1,489
Total Return
-85.11%
CAGR
-31.68%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +1.26% |
| Median | +0.25% |
| Best | +95.97% |
| Worst | -76.95% |
| % of Windows Positive | 50.4% |
1-Year (252 Trading Days)
| Average | +9.23% |
| Median | -12.61% |
| Best | +320.16% |
| Worst | -82.06% |
| % of Windows Positive | 40.6% |
3-Year (756 Trading Days)
| Average | -22.89% |
| Median | -24.05% |
| Best | +97.71% |
| Worst | -85.01% |
| % of Windows Positive | 22.0% |
Risk Metrics
| Maximum Drawdown | -90.44% |
| Average Drawdown | -58.07% |
| Drawdown Duration | 1252 Trading Days (Unrecovered) |
| Sortino Ratio | 0.37 |
| Calmar Ratio | -0.35 |
| CVaR (5%) | -13.25% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | -64.09% (-91.19% ann.) | $6409.27 | $0.00 | $0.00 | $0.00 |
| 2025 | +3.81% | +$380.75 | $0.00 | $0.00 | $0.00 |
| 2024 | +42.17% | +$4216.53 | $0.00 | $0.00 | $0.00 |
| 2023 | -49.57% | $4956.90 | $0.00 | $0.00 | $0.00 |
| 2022 | +74.00% | +$7399.99 | $0.00 | $0.00 | $0.00 |
| 2021 | -41.69% | $4169.09 | $0.00 | $0.00 | $0.00 |
| 2020 | +18.07% | +$1807.24 | $0.00 | $0.00 | $0.00 |
| 2019 | -30.00% | $3000.01 | $0.00 | $0.00 | $0.00 |
| 2018 | +22.06% | +$2205.89 | $0.00 | $0.00 | $0.00 |
| 2017 | +27.10% | +$2710.27 | $0.00 | $0.00 | $0.00 |
| 2016 | -21.09% | $2109.14 | $0.00 | $0.00 | $0.00 |
| 2015 | -6.09% | $609.42 | $0.00 | $0.00 | $0.00 |
| 2014 partial | +0.28% (+0.42% ann.) | +$27.78 | $0.00 | $0.00 | $0.00 |
Market Regimes
about| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | May 2, 2014 – February 19, 2020 | -28.06% | -5.52% | $2805.56 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -62.85% | -100.00% | $6284.59 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +189.18% | +452.11% | +$18917.79 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | +7.51% | +7.11% | +$750.75 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -32.46% | -34.08% | $3246.42 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | +5.09% | +2.72% | +$509.09 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – June 3, 2026 | -68.31% | -49.02% | $6831.35 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.